Kura Oncology Inc KURA
News
Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
Kura Oncology to Participate in Cantor Global Healthcare Conference
Kura Oncology Reports Second Quarter 2024 Financial Results
Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)
Kura Oncology to Report Second Quarter 2024 Financial Results
Kura Oncology Gets Breakthrough Designation For Leukemia Therapy